ATI Other Non-Current Liabilities increased by 18.8% to $307.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 99.2%, from $154.20M to $307.10M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 6.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $220.10M | $220.10M | $211.00M | $199.40M | $195.00M | $206.50M | $207.70M | $193.10M | $179.40M | $185.30M | $164.90M | $156.00M | $148.80M | $152.10M | $150.50M | $154.20M | $186.90M | $209.90M | $258.40M | $307.10M |
| QoQ Change | — | +0.0% | -4.1% | -5.5% | -2.2% | +5.9% | +0.6% | -7.0% | -7.1% | +3.3% | -11.0% | -5.4% | -4.6% | +2.2% | -1.1% | +2.5% | +21.2% | +12.3% | +23.1% | +18.8% |
| YoY Change | — | — | — | — | -11.4% | -6.2% | -1.6% | -3.2% | -8.0% | -10.3% | -20.6% | -19.2% | -17.1% | -17.9% | -8.7% | -1.2% | +25.6% | +38.0% | +71.7% | +99.2% |